Drugs Made In America Acquisition (DMAA) Current Assets (2024 - 2025)
Drugs Made In America Acquisition's (DMAA) quarterly Current Assets came in at $12191.0 in Q4 2025, up 144.26% YoY from $4991.0 in Q4 2024, and down 56.76% on a QoQ basis from $28196.0 in Q3 2025.
Drugs Made In America Acquisition (DMAA) Current Assets (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMAA) has 2 years of Current Assets data on file, last reported at $12191.0 in Q4 2025.
- Quarterly Current Assets rose 144.26% year-over-year to $12191.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12191.0 (up 144.26% YoY) and the FY2025 annual result came in at $12191.0, up 144.26% from the prior year.
- Current Assets retreated to $12191.0 in Q4 2025, from $28196.0 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $71019.0 in Q1 2025 to a low of $4991.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 962,384.00 |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 290,255.00 |
| 3 | Drugs Made In America Acquisition | 506.00 Mn | 506.00 Mn | - | 217,823.00 |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 197,500.00 |
| 5 | New Providence Acquisition Corp. III | 401.18 Mn | 401.18 Mn | - | 225,930.00 |
| 6 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 119,565.00 |
| 7 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 336,163.00 |
| 8 | Pioneer Acquisition I | 390.89 Mn | 653.32 Mn | - | 554,262.00 |
| 9 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 852,806.00 |
| 10 | Drugs Made In America Acquisition | 215.62 Mn | 215.62 Mn | - | 69,184.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12,191.00 |
| Sep 30, 2025 | 28,196.00 |
| Jun 30, 2025 | 49,726.00 |
| Mar 31, 2025 | 71,019.00 |
| Dec 31, 2024 | 4,991.00 |